Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:IMR Stock Latest News

Company AnnouncementsAC Immune Adds Tom Graney to Board Following Extraordinary General Meeting1M ago6K ACIU

RatingsFein Reiterates Buy on AC Immune as VacSYn Phase 2 Data Validate Platform; $12 Price Target Maintained1M agoACIU
Company AnnouncementsAC Immune Posts Strong Week-100 Phase 2 Data for Parkinson’s Vaccine ACI-71041M ago6K ACIU
The FlyAC Immune announces Phase 2 trial of ACI-7104 met primary endpoints1M agoACIU
Company AnnouncementsAC Immune Calls October EGM to Add Veteran Biopharma Financier Tom Graney to Board1M ago6K ACIU

Stifel’s Thomas Shrader Reiterates Buy on AC Immune, Citing Diversified Neuroscience Pipeline, Promising NLRP3 Data, and Strong Cash Runway

RatingsStifel’s Thomas Shrader Reiterates Buy on AC Immune, Citing Diversified Neuroscience Pipeline, Promising NLRP3 Data, and Strong Cash Runway2M agoACIU

Company AnnouncementsAC Immune posts positive first‑in‑human data for NLRP3 inhibitor ACI‑197642M ago6K ACIU

The FlyAC Immune receives fast track designation, clearance for ACI-7104 IND2M agoACIU

Company AnnouncementsAC Immune Wins FDA Fast Track for ACI-7104 in Early Parkinson’s Disease2M ago6K ACIU
RatingsAnalyst Reiterates Buy on AC Immune as 2H26 Catalysts Approach; Price Target Maintained at $122M agoACIU
Company AnnouncementsAC Immune Files First-Half 2026 Results and Corporate Update on Form 6-K2M ago6K ACIU
Company AnnouncementsAC Immune Unveils 12-Month Interim Data from ACI-24 Alzheimer’s Trial and Expands Takeda-Backed Program4M ago6K ACIU

AC Immune announces interim data from first three cohorts of ABATE trial

The FlyAC Immune announces interim data from first three cohorts of ABATE trial4M agoACIU

Company AnnouncementsAC Immune Shareholders Back Capital Band, Governance Slate and Pay Caps at June 11 AGM4M ago6K ACIU

Company AnnouncementsAC Immune Secures $4 Million Goradia Foundation Grant to Extend Phase 2 Parkinson’s Trial4M ago6K ACIU

The FlyAC Immune presents new Phase 1 data on uptake of ACI-196265M agoACIU
Company AnnouncementsAC Immune Sets June AGM and Reshapes Leadership as Long-Serving CEO Retires5M ago6K ACIU
Company AnnouncementsAC Immune CEO and Co-Founder Andrea Pfeifer to Retire at June 11 AGM; Board Chair Martin Zügel Named Interim Chief5M ago6K ACIU
The FlyAC Immune reports Q1 EPS (15c), consensus (14c)6M agoACIU

AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial

Company AnnouncementsAC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial6M ago6K ACIU

Company AnnouncementsAC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline6M ago6K ACIU

Pre-EarningsIs ACIU a Buy, Before Earnings?6M agoACIU